These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 34347202)
1. Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction. Nicolas J; Beerkens F; Cao D; Sartori S; Pivato CA; Qiu H; Giustino G; Chiarito M; Claessen BE; Zhang Z; Nardin M; Razuk V; Jones D; Camaj A; Power D; Banashefski B; Sweeny J; Baber U; Dangas G; Sharma SK; Kini A; Mehran R J Thromb Thrombolysis; 2022 Jan; 53(1):20-29. PubMed ID: 34347202 [TBL] [Abstract][Full Text] [Related]
2. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry. Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447 [TBL] [Abstract][Full Text] [Related]
3. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome. Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715 [TBL] [Abstract][Full Text] [Related]
4. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. Cao D; Mehran R; Dangas G; Baber U; Sartori S; Chandiramani R; Stefanini GG; Angiolillo DJ; Capodanno D; Urban P; Morice MC; Krucoff M; Goel R; Roumeliotis A; Sweeny J; Sharma SK; Kini A J Am Coll Cardiol; 2020 Jun; 75(21):2711-2722. PubMed ID: 32466887 [TBL] [Abstract][Full Text] [Related]
5. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention. Abu-Assi E; Raposeiras-Roubín S; Cespón Fernández M; Caneiro Queija B; Melendo Viu M; Íñiguez Romo A Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):375-383. PubMed ID: 33865751 [TBL] [Abstract][Full Text] [Related]
6. Relationship between in-hospital event rates and high bleeding risk score in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Tsukizawa T; Fujihara M Cardiovasc Interv Ther; 2022 Jul; 37(3):490-496. PubMed ID: 34406605 [TBL] [Abstract][Full Text] [Related]
7. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores. Ueki Y; Bär S; Losdat S; Otsuka T; Zanchin C; Zanchin T; Gragnano F; Gargiulo G; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Heg D; Valgimigli M; Windecker S; Räber L EuroIntervention; 2020 Aug; 16(5):371-379. PubMed ID: 32065586 [TBL] [Abstract][Full Text] [Related]
8. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention. Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044 [TBL] [Abstract][Full Text] [Related]
9. Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition. Gragnano F; Spirito A; Corpataux N; Vaisnora L; Galea R; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Bär S; Ueki Y; Capodanno D; Urban P; Pocock SJ; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M EuroIntervention; 2021 Dec; 17(11):e898-e909. PubMed ID: 34105513 [TBL] [Abstract][Full Text] [Related]
10. Temporal Trends of Major Bleeding and Its Prediction by the Academic Research Consortium-High Bleeding Risk Criteria in Acute Myocardial Infarction. Byun S; Choo EH; Oh GC; Lim S; Choi IJ; Lee KY; Lee SN; Hwang BH; Kim CJ; Park MW; Park CS; Kim HY; Yoo KD; Jeon DS; Youn HJ; Chung WS; Kim MC; Jeong MH; Yim HW; Ahn Y; Chang K J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207261 [TBL] [Abstract][Full Text] [Related]
11. Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients. Silverio A; Di Maio M; Buccheri S; De Luca G; Esposito L; Sarno G; Vecchione C; Galasso G Int J Cardiol; 2022 Jan; 347():8-15. PubMed ID: 34774882 [TBL] [Abstract][Full Text] [Related]
12. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients with Acute Myocardial Infarction. Matsumoto T; Saito Y; Sato T; Yamashita D; Suzuki S; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y J Atheroscler Thromb; 2023 Mar; 30(3):299-309. PubMed ID: 35613875 [TBL] [Abstract][Full Text] [Related]
13. De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy. Kim MC; Ahn SG; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Lee JW; Youn YJ; Kim HY; Yoo KD; Jeon DS; Shin ES; Jeong YH; Chang K; Ahn Y EuroIntervention; 2023 Dec; 19(10):e832-e843. PubMed ID: 37724337 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of the Japanese high bleeding risk criteria and its prognostic significance for fatal bleeding in patients with acute myocardial infarction. Sotomi Y; Hikoso S; Nakatani D; Suna S; Dohi T; Mizuno H; Okada K; Kida H; Oeun B; Sunaga A; Sato T; Kitamura T; Sakata Y; Sato H; Hori M; Komuro I; Sakata Y; Heart Vessels; 2021 Oct; 36(10):1484-1495. PubMed ID: 33743047 [TBL] [Abstract][Full Text] [Related]
15. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention. Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI. Chiarito M; Kini A; Roumeliotis A; Cao D; Power D; Sartori S; Reisman A; Zhang Z; Mtisi T; Nicolas J; Nardin M; Stefanini G; Baber U; Giustino G; Sweeny J; Mehran R; Sharma S; Dangas G JACC Cardiovasc Interv; 2021 Nov; 14(22):2447-2457. PubMed ID: 34794650 [TBL] [Abstract][Full Text] [Related]
17. Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies. Kuno T; Claessen B; Cao D; Chandiramani R; Guedeney P; Sorrentino S; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Rau V; Ruster K; Wang J; Valgimigli M; Mehran R J Thromb Thrombolysis; 2021 Aug; 52(2):419-428. PubMed ID: 33709255 [TBL] [Abstract][Full Text] [Related]